Novartis
NVS
NVS
877 hedge funds and large institutions have $19.5B invested in Novartis in 2016 Q2 according to their latest regulatory filings, with 69 funds opening new positions, 341 increasing their positions, 311 reducing their positions, and 56 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
4% more call options, than puts
Call options by funds: $62.8M | Put options by funds: $60.5M
0% more funds holding
Funds holding: 874 → 877 (+3)
0.1% more ownership
Funds ownership: 9.94% → 10.04% (+0.1%)
Holders
877
Holding in Top 10
37
Calls
$62.8M
Puts
$60.5M
Top Buyers
| 1 | +$128M | |
| 2 | +$109M | |
| 3 | +$93.8M | |
| 4 |
Aristotle Capital Management
Los Angeles,
California
|
+$54.7M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$39.5M |
Top Sellers
| 1 | -$276M | |
| 2 | -$82.8M | |
| 3 | -$56.8M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$50.8M |
| 5 |
D.E. Shaw & Co
New York
|
-$48.2M |